Literature DB >> 20926954

Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.

Annelies Van Rie1, Daniel Westreich, Ian Sanne.   

Abstract

OBJECTIVE: To determine tuberculosis (TB) incidence rates and risk factors among individuals receiving antiretroviral treatment (ART).
DESIGN: Observational cohort in Johannesburg, South Africa.
METHODS: Incident TB was classified as early (less than 6 months of ART) or late (greater than 6 months of ART) incident TB. CD4 cell counts, viral load, body mass index, and hemoglobin were measured 6-monthly. Hazard ratios for factors associated with early and late incident TB were assessed using Cox proportional hazards regression.
RESULTS: During 13,416 person-years of follow-up, 501 TB cases occurred among 7536 individuals, corresponding to a 10% risk in the first 4 years of ART and an overall incidence rate of 4.2 cases/100 person-years. The highest incidence rate (21.7 per 100 person-years) was observed in the first 3 months of ART among people with CD4 count below 50 cells/mm3. Low baseline CD4 count, anemia, and low body mass index were the strongest risk factors for early incident TB. Low updated CD4 count, low updated body mass index, anemia, and high viral load on ART were strong risk factors for late incident TB.
CONCLUSIONS: Severity of HIV disease and unfavorable response to ART are associated with early and late incident TB, respectively. Early ART initiation and intensified TB screening at ART initiation are crucial to reduce incident TB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20926954      PMCID: PMC3319435          DOI: 10.1097/QAI.0b013e3181f9fb39

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  24 in total

1.  HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group.

Authors:  J L Jones; D L Hanson; M S Dworkin; K M DeCock
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

Review 2.  A consistent log-linear relationship between tuberculosis incidence and body mass index.

Authors:  Knut Lönnroth; Brian G Williams; Peter Cegielski; Christopher Dye
Journal:  Int J Epidemiol       Date:  2009-10-09       Impact factor: 7.196

3.  Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.

Authors:  E Girardi; G Antonucci; P Vanacore; M Libanore; I Errante; A Matteelli; G Ippolito
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

4.  Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.

Authors:  Guilherme Santoro-Lopes; Ana Maria Felix de Pinho; Lee H Harrison; Mauro Schechter
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

5.  Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.

Authors:  M Dembélé; N Saleri; A C C Carvalho; T Saouadogo; A D Hien; I Zabsonre; S T Koala; J Simporé; A Matteelli
Journal:  Int J Tuberc Lung Dis       Date:  2010-03       Impact factor: 2.373

6.  Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.

Authors:  S Rajasekaran; K Raja; L Jeyaseelan; S Vijilat; Krithiga Priya; Kuralmozhi Mohan; Anwar Parvez; A Mahilmaran; C Chandrasekar
Journal:  Indian J Tuberc       Date:  2009-04

7.  Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Authors:  Motasim Badri; Douglas Wilson; Robin Wood
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

8.  Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Authors:  Stephen D Lawn; Landon Myer; David Edwards; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

9.  Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.

Authors:  Stephen D Lawn; David J Edwards; Katharina Kranzer; Monica Vogt; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

10.  Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.

Authors:  Abraham Miranda; Meade Morgan; Leda Jamal; Kayla Laserson; Draurio Barreira; Guida Silva; Joseney Santos; Charles Wells; Patricia Paine; Denise Garrett
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

View more
  55 in total

1.  Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.

Authors:  Suzue Saito; Philani Mpofu; E Jane Carter; Lameck Diero; Kara K Wools-Kaloustian; Constantin T Yiannoutsos; Musick S Beverly; Simon Tsiouris; Geoffrey R Somi; John Ssali; Denis Nash; Batya Elul
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

2.  Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.

Authors:  Timothy R Sterling; Nigel A Scott; Jose M Miro; Guilherme Calvet; Alberto La Rosa; Rosa Infante; Michael P Chen; Debra A Benator; Fred Gordin; Constance A Benson; Richard E Chaisson; M Elsa Villarino
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

3.  A hospital-based tuberculosis focal point to improve tuberculosis care provision in a very high burden setting.

Authors:  E Jong; I M Sanne; A van Rie; C N Menezes
Journal:  Public Health Action       Date:  2013-03-21

4.  Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.

Authors:  Taraz Samandari; Tefera B Agizew; Samba Nyirenda; Zegabriel Tedla; Thabisa Sibanda; Barudi Mosimaneotsile; Oaitse I Motsamai; Nong Shang; Charles E Rose; James Shepherd
Journal:  AIDS       Date:  2015-01-28       Impact factor: 4.177

5.  Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis.

Authors:  J Morgan Freiman; Karen R Jacobson; Winnie R Muyindike; C Robert Horsburgh; Jerrold J Ellner; Judith A Hahn; Benjamin P Linas
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

Review 6.  Undernutrition and Tuberculosis: Public Health Implications.

Authors:  Pranay Sinha; Juliana Davis; Lauren Saag; Christine Wanke; Padmini Salgame; Jackson Mesick; C Robert Horsburgh; Natasha S Hochberg
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

7.  Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study.

Authors:  Mark W Tenforde; Ashish Yadav; David W Dowdy; Nikhil Gupte; Rupak Shivakoti; Wei-Teng Yang; Noluthando Mwelase; Cecilia Kanyama; Sandy Pillay; Wadzanai Samaneka; Breno Santos; Selvamuthu Poongulali; Srikanth Tripathy; Cynthia Riviere; Sima Berendes; Javier R Lama; Sandra W Cardoso; Patcharaphan Sugandhavesa; Parul Christian; Richard D Semba; Thomas B Campbell; Amita Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

Review 8.  Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Stephen D Lawn; Anthony D Harries; Graeme Meintjes; Haileyesus Getahun; Diane V Havlir; Robin Wood
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

9.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

10.  Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays.

Authors:  Andrew D Kerkhoff; Robin Wood; Monica Vogt; Stephen D Lawn
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.